Novartis Institute for Tropical Diseases (NITD)
Novartis invests in a small-molecule drug discovery research institute dedicated to new treatments and prevention methods for dengue, tuberculosis and malaria.
The Novartis Institute for Tropical Diseases aims to discover novel treatments and prevention methods for major tropical diseases and contributes to education by its teaching and training opportunities.
NITD provides a lively community of more than 100 international scientists located in Singapore with 30 collaborators around the globe.
NEHCRI is a joint research initiative that lays the groundwork for the clinical development of new medicines against tropical diseases.
Master’s degree infectious diseases ›
NITD teams with University of Basel, Swiss Tropical Institute and National University of Singapore to offer a joint Master of Science program in infectious diseases, vaccinology and drug discovery.
Research & Development at NITD ›
Drug discovery expertise and cutting-edge technologies of Novartis combine to fight infectious tropical diseases: dengue, tuberculosis and malaria.
NITD works through a strong network of scientific partnerships and collaborations in Singapore and around the world. NITD is constantly seeking new collaboration opportunities.
Explore a bibliography of publications resulting from the work of NITD.
Corporate Citizenship
Corporate citizenship at Novartis is an integral part of how we operate and a key to our success.
Collaborations map
Neglected diseases
We aim to discover new treatments and prevention methods for major tropical diseases. Learn more about the main tropical diseases:
